Quick Takeaways
- Steven H. Stein has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,478,445.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Steven H. Stein
- Location
- Wilmington, DE
- Summary
- The estimated net worth of Steven H. Stein is at least $3,478,445 dollars as of 21 Jan 2026. Steven H. Stein is the EVP & Chief Medical Officer of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $3.48M.
- Signature
- /s/ Elizabeth Feeney, Attorney-In-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Steven H. Stein and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: INCYTE CORP ($3,478,445).
- Past-year value change for that position: -$5,724,778.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Steven H. Stein
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | EVP & Chief Medical Officer | $3,478,445 | -$5,724,778 | -62% | 16 Jan 2026 |
| THRX | Theseus Pharmaceuticals, Inc. | Director | $0 | 14 Feb 2024 | ||
| KURA | Kura Oncology, Inc. | Director | 21 Jun 2022 | |||
| RPTX | Repare Therapeutics Inc. | Director | 17 Jun 2024 |
Insider Transactions Reported by Steven H. Stein:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.